Australia's biotech startups fear new tax policies will hurt innovation

Updated at: June 9, 2026 at 02:45 AM

Australia's vibrant biotechnology sector is currently facing significant uncertainty following proposed changes to the Research and Development Tax Incentive (RDTI) in the 2026-27 Federal Budget.

nounAustralia

adjectivevibrant

verbface

noununcertainty

The government intends to limit the refundable tax offset to companies younger than 10 years, a move that has sparked alarm across the industry.

noungovernment

nouncompany

nounalarm

Health and life sciences organizations argue this policy is unworkable, as the path from research to market for life-saving medical products often spans 17 years or longer.

adjectiveunworkable

nounmarket

Leaders fear that without this support, many home-grown companies may move their clinical programs and talent to more supportive overseas jurisdictions.

nouncompany

With the sector supporting 350,000 jobs and representing a massive export industry, concerns are growing that these new tax policies, combined with potential changes to Capital Gains Tax, could stifle innovation and discourage future investment in Australian health technology.

nouninnovation

🎉

End of article

You read 5 focus sentences.

Challenge Mode

Comprehension Questions

What is the primary reason the biotechnology industry objects to the new 10-year RDTI limit?

It fails to account for the fact that medical product development often takes longer than 10 years.

It requires companies to pay higher corporate taxes immediately.

It restricts the number of new startups that can enter the market.

Reveal Answer

✓

Correct Choice

It fails to account for the fact that medical product development often takes longer than 10 years.

What is the 'valley of death' in the context of biotech startups?

A period where companies focus entirely on marketing rather than research.

A phase of high expenditure and no revenue prior to clinical success and regulatory approval.

The final stage of clinical trials where projects are most likely to fail.

Reveal Answer

✓

Correct Choice

A phase of high expenditure and no revenue prior to clinical success and regulatory approval.

How did major industry bodies respond to the government's proposal?

They expressed that they were blindsided by the lack of prior consultation.

They praised the government for increasing tax transparency.

They withdrew their support for the current government budget entirely.

Reveal Answer

✓

Correct Choice

They expressed that they were blindsided by the lack of prior consultation.

Why are biotech companies considering moving their operations overseas?

Because foreign countries offer lower costs for laboratory equipment.

Because they want to be closer to the major global consumers of medicine.

They fear the tax changes will make Australia a less supportive environment for innovation.

Reveal Answer

✓

Correct Choice

They fear the tax changes will make Australia a less supportive environment for innovation.

What is the broader economic impact of the biotechnology sector in Australia?

It is a major value-add export industry that supports over 350,000 jobs.

It is responsible for 50% of the country's total annual tax revenue.

It primarily focuses on exporting raw materials and natural resources.

Reveal Answer

✓

Correct Choice

It is a major value-add export industry that supports over 350,000 jobs.

Learn faster with Ringoo apps

Trace your learning progress and get real-time feedback with interactive exercises.

App Store Google Play